Depression, anxiety. Major depressive disorder, single episode
Conditions
Interventions
Intervention 1: Intervention group: For four weeks, he consumes one tablespoon of Ocimum basilicum hydroalcoholic extract syrup at a dose of 220 mg/ml every night. This syrup will be produced by the o
Sponsors
Fasa University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: Men and women between 18 and 65 years old People with major depressive disorder based on DSM 5 criteria Obtaining a minimum score of 18 in the Hamilton Anxiety Questionnaire Not taking any new anti-anxiety medication in the last 1 month Not suffering from significant internal diseases such as heart and lung failure, cancer, vascular disease, rheumatological disease, history of seizures and hypothyroidism, etc. Not using anticoagulant or anti-platelet drugs such as warfarin, heparin, aspirin, etc. No drug and alcohol addiction
Exclusion criteria
Exclusion criteria: Any allergy to Ocimum basilicum and its products Pregnancy or breastfeeding Hypersensitivity to specific serotonin re-uptake inhibitor drugs Patients who will not have proper follow-up
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Depression score in Beck questionnaire. Timepoint: Before starting the study and 4 weeks after taking the drug. Method of measurement: Based on the Beck Depression Questionnaire.;Anxiety score in Hamilton questionnaire. Timepoint: Before starting the study and 4 weeks after taking the drug. Method of measurement: Based on Hamilton anxiety questionnaire. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactKiarash Zare
Fasa University of Medical Sciences
Outcome results
None listed